N
Naveed Ishaque
Researcher at Charité
Publications - 53
Citations - 4577
Naveed Ishaque is an academic researcher from Charité. The author has contributed to research in topics: DNA methylation & Hyaloperonospora arabidopsidis. The author has an hindex of 24, co-authored 53 publications receiving 2913 citations. Previous affiliations of Naveed Ishaque include Martin Luther University of Halle-Wittenberg & Sainsbury Laboratory.
Papers
More filters
Journal ArticleDOI
COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.
Robert Lorenz Chua,Soeren Lukassen,Saskia Trump,Bianca P Hennig,Daniel Wendisch,Fabian Pott,Olivia Debnath,Loreen Thürmann,Florian Kurth,Florian Kurth,Maria Theresa Völker,Julia Kazmierski,Bernd Timmermann,Sven Twardziok,Stefan Schneider,Felix Machleidt,Holger Müller-Redetzky,Melanie Maier,Alexander Krannich,Sein Schmidt,Felix Balzer,Johannes Liebig,Jennifer Loske,Norbert Suttorp,Jürgen Eils,Naveed Ishaque,Uwe G. Liebert,Christof von Kalle,Andreas C. Hocke,Martin Witzenrath,Christine Goffinet,Christian Drosten,Sven Laudi,Irina Lehmann,Christian Conrad,Leif E. Sander,Roland Eils,Roland Eils +37 more
TL;DR: The data suggest that pharmacologic inhibition of the CCR1 and/or CCR5 pathways might suppress immune hyperactivation in critical COVID-19, which likely contribute to clinical observations of heightened inflammatory tissue damage, lung injury and respiratory failure.
Journal ArticleDOI
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott,Paul A. Northcott,Ivo Buchhalter,Ivo Buchhalter,A. Sorana Morrissy,Volker Hovestadt,Joachim Weischenfeldt,Tobias Ehrenberger,Susanne Gröbner,Maia Segura-Wang,Thomas Zichner,Vasilisa A. Rudneva,Hans-Jörg Warnatz,Nikos Sidiropoulos,Aaron H. Phillips,Steven E. Schumacher,Kortine Kleinheinz,Sebastian M. Waszak,Serap Erkek,Serap Erkek,David T.W. Jones,Barbara C. Worst,Marcel Kool,Marc Zapatka,Natalie Jäger,Lukas Chavez,Barbara Hutter,Matthias Bieg,Nagarajan Paramasivam,Nagarajan Paramasivam,Michael Heinold,Michael Heinold,Zuguang Gu,Naveed Ishaque,Christina Jäger-Schmidt,Charles D. Imbusch,Alke Jugold,Daniel Hübschmann,Daniel Hübschmann,Daniel Hübschmann,Thomas Risch,Vyacheslav Amstislavskiy,Francisco German Rodriguez Gonzalez,Ursula D. Weber,Stephan Wolf,Giles W. Robinson,Xin Zhou,Gang Wu,David Finkelstein,Yanling Liu,Florence M.G. Cavalli,Betty Luu,Vijay Ramaswamy,Xiaochong Wu,Jan Koster,Marina Ryzhova,Yoon Jae Cho,Scott L. Pomeroy,Christel Herold-Mende,Martin U. Schuhmann,Martin Ebinger,Linda M. Liau,Jaume Mora,Roger E. McLendon,Nada Jabado,Toshihiro Kumabe,Eric Chuah,Yussanne Ma,Richard A. Moore,Andrew J. Mungall,Karen Mungall,Nina Thiessen,Kane Tse,Tina Wong,Steven J.M. Jones,Olaf Witt,Till Milde,Andreas von Deimling,David Capper,Andrey Korshunov,Marie-Laure Yaspo,Richard W. Kriwacki,Amar Gajjar,Jinghui Zhang,Rameen Beroukhim,Ernest Fraenkel,Jan O. Korbel,Benedikt Brors,Matthias Schlesner,Roland Eils,Roland Eils,Marco A. Marra,Stefan M. Pfister,Stefan M. Pfister,Michael D. Taylor,Peter Lichter +95 more
TL;DR: The application of integrative genomics to an extensive cohort of clinical samples derived from a single childhood cancer entity revealed a series of cancer genes and biologically relevant subtype diversity that represent attractive therapeutic targets for the treatment of patients with medulloblastoma.
Journal ArticleDOI
Signatures of adaptation to obligate biotrophy in the Hyaloperonospora arabidopsidis genome
Laura Baxter,Sucheta Tripathy,Naveed Ishaque,Nico Boot,Adriana Cabral,Eric Kemen,Marco Thines,Marco Thines,Audrey M. V. Ah-Fong,Ryan G. Anderson,Wole Badejoko,Peter D. Bittner-Eddy,Jeffrey L. Boore,Marcus C. Chibucos,Mary Coates,Paramvir S. Dehal,Kim D. Delehaunty,Suomeng Dong,Suomeng Dong,Polly Downton,Bernard Dumas,Bernard Dumas,Georgina Fabro,Catrina Fronick,Susan I. Fuerstenberg,Lucinda Fulton,Elodie Gaulin,Elodie Gaulin,Francine Govers,Linda Karen Hughes,Sean Humphray,Rays H. Y. Jiang,Rays H. Y. Jiang,Howard S. Judelson,Sophien Kamoun,Kim Kyung,Harold J. G. Meijer,Patrick Minx,Paul Morris,Joanne O. Nelson,Vipa Phuntumart,Dinah Qutob,Anne P. Rehmany,Alejandra Rougon-Cardoso,Peter Ryden,Trudy Torto-Alalibo,David J. Studholme,Yuanchao Wang,Joe Win,Jonathan Wood,Sandra W. Clifton,Jane Rogers,Guido Van den Ackerveken,Jonathan D. G. Jones,John M. McDowell,Jim Beynon,Brett M. Tyler,Brett M. Tyler +57 more
TL;DR: The genome sequence of the oomycete Hyaloperonospora arabidopsidis is reported, an obligate biotroph and natural pathogen of Arabidopsis thaliana, which exhibits dramatic reductions in genes encoding RXLR effectors, proteins associated with zoospore formation and motility, and enzymes for assimilation of inorganic nitrogen and sulfur.
Journal ArticleDOI
Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors
Jenny Wegert,Naveed Ishaque,Romina Vardapour,Christina Geörg,Zuguang Gu,Matthias Bieg,Barbara Ziegler,Sabrina Bausenwein,N. Nourkami,Nicole Ludwig,Andreas Keller,Clemens Grimm,Susanne Kneitz,Richard D. Williams,Tasnim Chagtai,Kathy Pritchard-Jones,Peter van Sluis,Richard Volckmann,Jan Koster,Rogier Versteeg,T Acha,Maureen J. O'Sullivan,Peter K. Bode,Felix Niggli,Godelieve A.M. Tytgat,Harm van Tinteren,Marry M. van den Heuvel-Eibrink,Eckart Meese,Christian Vokuhl,Ivo Leuschner,Norbert Graf,Roland Eils,Roland Eils,Stefan M. Pfister,Marcel Kool,Manfred Gessler +35 more
TL;DR: Recurrent mutations included a hotspot mutation (Q177R) in the homeo-domain of SIX1 and SIX2 in tumors with high proliferative potential, which was functionally validated in cell lines expressing mutant DROSHA.
Journal ArticleDOI
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
Ahmed Sadik,Luis F. Somarribas Patterson,Selcen Öztürk,Soumya R. Mohapatra,Verena Panitz,Philipp F Secker,Pauline Pfänder,Stefanie Loth,Heba Salem,Mirja Tamara Prentzell,Bianca Berdel,Murat Iskar,Erik Faessler,Friederike Reuter,Isabelle Kirst,Verena Kalter,Kathrin I. Foerster,Evelyn Jäger,Carina Ramallo Guevara,Mansour Sobeh,Thomas Hielscher,Gernot Poschet,Annekathrin Reinhardt,Jessica C. Hassel,Marc Zapatka,Udo Hahn,Andreas von Deimling,Carsten Hopf,Rita Schlichting,Beate I. Escher,Jürgen Burhenne,Walter E. Haefeli,Naveed Ishaque,Alexander Böhme,Sascha Schäuble,Kathrin Thedieck,Saskia Trump,Martina Seiffert,Christiane A. Opitz +38 more
TL;DR: A pan-tissue AHR signature revealed that across 32 tumor entities, interleukin-4-induced-1 (IL4I1) associates more frequently with AHR activity than IDO1 or TDO2, hitherto recognized as the main Trp-catabolic enzymes.